Paion AG
XETRA:PA8
Paion AG
Revenue
Paion AG
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Paion AG
XETRA:PA8
|
Revenue
€33.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Revenue
€3.8B
|
CAGR 3-Years
99%
|
CAGR 5-Years
97%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Revenue
€238.3m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
Immatics NV
NASDAQ:IMTX
|
Revenue
€54m
|
CAGR 3-Years
20%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Revenue
€684.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
3%
|
|
Formycon AG
XETRA:FYB
|
Revenue
€42.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
See Also
What is Paion AG's Revenue?
Revenue
33.2m
EUR
Based on the financial report for Dec 31, 2022, Paion AG's Revenue amounts to 33.2m EUR.
What is Paion AG's Revenue growth rate?
Revenue CAGR 1Y
366%
Over the last year, the Revenue growth was 366%.